Assaying potential carcinogens with Drosophila.
Drosophila offers many advantages for the detection of mutagenic activity of carcinogenic agents. It provides the quickest assay system for detecting mutations in animals today. Its generation time is short, and Drosophila is cheap and easy to breed in large numbers. The simple genetic testing methods give unequivocal answers about the whole spectrum of relevant genetic damage. A comparison of the detection capacity of assays sampling different kinds of genetic damage revealed that various substances are highly effective in inducing mutations but do not produce chromosome breakage effects at all, or only at much higher concentrations than those required for mutation induction. Of the different assay systems available, the classical sex-linked recessive lethal test deserves priority, in view of its superior capacity to detect mutagens. Of practical importance is also its high sensitivity, because a large number of loci in one fifth of the genome is tested for newly induced forward mutations, including small deletions. The recent findings that Drosophila is capable of carrying out the same metabolic activation reactions as the mammalian liver makes the organism eminently suitable for verifying results obtained in prescreening with fast microbial assay systems. An additional advantage in this respect is the capacity of Drosophila for detecting short-lived activation products, because intracellular metabolic activation appears to occur within the spermatids and spermatocytes.
D000818:Animals; D001388:Aziridines / Q000494:pharmacology; D001681:Biological Assay; D002273:Carcinogens / Q000494:pharmacology*; D002869:Chromosome Aberrations; D004052:Diethylnitrosamine / Q000494:pharmacology; D004330:Drosophila / Q000187:drug effects*; D005799:Genes, Dominant / Q000187:drug effects; D005804:Genes, Lethal / Q000187:drug effects; D005808:Genes, Recessive / Q000187:drug effects; D007928:Lethal Dose 50; D008741:Methyl Methanesulfonate / Q000494:pharmacology; D009153:Mutagens / Q000494:pharmacology*; D011809:Quinones / Q000494:pharmacology; D012730:Sex Chromosomes / Q000187:drug effects
D001388:Aziridines; D002273:Carcinogens; D009153:Mutagens; D011809:Quinones; D004052:Diethylnitrosamine; D008741:Methyl Methanesulfonate